Oxatomide (Compound)

Synonyms:oxatomide, 60607-34-3, Tinset, Celtect, Cobiona, Dasten, KW-4354, 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one, 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one, C27H30N4O, 1-(3-(4-Benzhydrylpiperazin-1-yl)propyl)-1H-benzo[d]imidazol-2(3H)-one, R-35443, R 35,443, Oxatimide, NSC-309710, J31IL9Z2EE, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one, MLS000028549, Oxatomidum, DTXSID4045181, Oxatomida, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone, 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-2-benzimidazolinone, NCGC00015774-03, SMR000058301, Oxatomidum [INN-Latin], 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-, Oxatomida [INN-Spanish], DTXCID2025181, McN-JR 35443, R 35443, Celtect (TN), CAS-60607-34-3, EINECS 262-320-9, CBMicro_024634, UNII-J31IL9Z2EE, BRN 4724760, Oxatomide (JAN/USAN/INN), 1-{3-[4-(diphenylmethyl)-1-piperazinyl]propyl}-1,3-dihydro-2H-benzimidazol-2-one, Oxatomide [USAN:INN:BAN:JAN], Oxatomide, >=99%, OXATOMIDE [INN], OXATOMIDE [JAN], OXATOMIDE [MI], OXATOMIDE [USAN], Lopac-O-9387, OXATOMIDE [MART.], O 9387, cid_4615, OXATOMIDE [WHO-DD], Lopac0_000924, Oprea1_338592, REGID_for_CID_4615, SCHEMBL28824, CHEMBL13828, BDBM76863, CHEBI:31943, HMS2089N07, HMS2231H12, HMS3372K08, Tox21_110219, CCG-11811, NSC309710, NSC771641, AKOS000507212, Tox21_110219_1, AB04841, DB12877, KS-1375, NSC 309710, NSC-771641, 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-, NCGC00015774-01, NCGC00015774-02, NCGC00015774-04, NCGC00015774-05, NCGC00015774-06, NCGC00094235-01, NCGC00094235-02, BIM-0024581.P001, DB-053668, HY-123205, CS-0081837, EU-0100924, FT-0630723, D01773, AB01227629-02, A832804, EN300-25890425, SR-01000076051, Q2071515, SR-01000076051-1, W-105243, 3-[3-(4-benzhydrylpiperazino)propyl]-1H-benzimidazol-2-one, 3-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1H-benzimidazol-2-one, 3-[3-[4-(diphenylmethyl)piperazin-1-yl]propyl]-1H-benzimidazol-2-one, 1-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one, 1-{3-[4-(diphenylmethyl)-1-piperazinyl}-propyl}-1,3-dihydro-2H-benzimidazol-2-one, 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-2,3-dihydro-1H-1,3-benzodiazol-2-one, 1{-[4-(diphenylmethyl)-1-piperzinyl]propyl}-1,3-dihydro-2H-benzimidazol-2-one

Pubchem:PUBCHEM:4615

Id:43eecef7-baaf-5d19-96cd-05e264123b12

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Oxatomide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Oxatomide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Oxatomide.

Results found

Linked to

	Label	Description
	BRD-K02079473-001-01-3 Substance (Entity type)	A Substance
	DCSTRUCT ID 02014 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02014; PubChem_CID:4615, FILE=drugcentral_drug_02014.json)
	oxatomide (1bddde43-691f-4016-abf0-2b472866505a) Collection (Entity type)	Metadatata for oxatomide
	Oxatomide positively regulates SCPEP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxatomide negatively regulates TLR4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxatomide positively regulates TGFBI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxatomide positively regulates HOXA10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxatomide negatively regulates BMP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Oxatomide negatively regulates CXCL2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea in similarity relationship with Oxatomide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS